Peptides administered subcutaneously are processed by antigen-presenting cells, and repeated exposure can trigger antibody formation against the administered sequence
During periods of significant illness or dehydration, patients should seek medical advice and may need to temporarily interrupt GLP-1 treatment to reduce the risk of acute kidney injury and electrolyte imbalances
Matters if this starts to drive our overall approach to these long-term conditions away from providing the means to live well versus medicating at scale perhaps
For a neat contrast, see our Corpse Husband face reveal timeline with dates and citations
For individuals planning conception while managing weight or type 2 diabetes, the decision to continue, pause, or adjust GLP-1 therapy involves multiple factors: metabolic health status, fertility timelines, and individual clinical context